Lactate enhances motility of tumor cells and inhibits monocyte migration and cytokine release

International Journal of Oncology

Volumn 39, Issue 2, 2011, Pages 453-463

  Goetze, Kristina ^a   Walenta, Stefan ^a   Ksiazkiewicz, Magdalena ^b,c   Kunz Schughart, Leoni A ^b   Mueller Klieser, Wolfgang ^a  

^a JOHANNES GUTENBERG UNIVERSITY   (Germany)

^b DRESDEN UNIVERSITY OF TECHNOLOGY   (Germany)

^c UNIVERSITY OF REGENSBURG   (Germany)

Author keywords

Cell migration; Cytokines; Lactate; Microenvironment; Monocytes; Tumor

Indexed keywords

CYTOKINE; INTERLEUKIN 6; LACTIC ACID; PYRUVIC ACID; TUMOR NECROSIS FACTOR;

ARTICLE; CANCER CELL CULTURE; CELL MIGRATION; CELL MOTILITY; CONTROLLED STUDY; CYTOKINE RELEASE; HEAD AND NECK CARCINOMA; HUMAN; HUMAN CELL; LEUKOCYTE MIGRATION; MONOCYTE; PRIORITY JOURNAL;

CELL LINE, TUMOR; CELL MOVEMENT; CYTOKINES; HUMANS; INTEGRIN BETA CHAINS; LACTIC ACID; MONOCYTES; NEOPLASMS;

EID: 79960029992     PISSN: 10196439     EISSN: 17912423     Source Type: Journal    
DOI: 10.3892/ijo.2011.1055     Document Type: Article

References (63)

1. Schwickert G, Walenta S, Sundfor K, Rofstad EK and Mueller-Klieser W: Correlation of high lactate levels in human cervical cancer with incidence of metastasis. Cancer Res 55: 4757-4759, 1995
2. Walenta S, Salameh A, Lyng H, Evensen JF, Mitze M, Rofstad EK and Mueller-Klieser W: Correlation of high lactate levels in head and neck tumors with incidence of metastasis. Am J Pathol 150: 409-415, 1997 (Pubitemid 27073770)
3. Brizel DM, Schroeder T, Scher RL, Walenta S, Clough RW, Dewhirst MW and Mueller-Klieser W: Elevated tumor lactate concentrations predict for an increased risk of metastases in head-and-neck cancer. Int J Radiat Oncol Biol Phys 51: 349-353, 2001. (Pubitemid 32884281)
4. Walenta S, Wetterling M, Lehrke M, Schwickert G, Sundfor K, Rofstad EK and Mueller-Klieser W: High lactate levels predict likelihood of metastases, tumor recurrence, and restricted patient survival in human cervical cancers. Cancer Res 60: 916-921, 2000. (Pubitemid 30129526)
5. Walenta S, Chau TV, Schroeder T, Lehr HA, Kunz-Schughart LA, Fuerst A and Mueller-Klieser W: Metabolic classification of human rectal adenocarcinomas: a novel guideline for clinical oncologists? J Cancer Res Clin Oncol 129: 321-326, 2003.
6. Walenta S, Schroeder T and Mueller-Klieser W: Metabolic mapping with bioluminescence: basic and clinical relevance. Biomol Eng 18: 249-262, 2002. (Pubitemid 34158559)
7. 2 availability on human cancer. Nat Rev Cancer 8: 967-975, 2008.
8. Chen Z, Lu W, Garcia-Prieto C and Huang P: The Warburg effect and its cancer therapeutic implications. J Bioenerg Biomembr 39: 267-274, 2007. (Pubitemid 47619379)
9. DeBerardinis RJ, Sayed N, Ditsworth D and Thompson CB: Brick by brick: metabolism and tumor cell growth. Curr Opin Genet Dev 18: 54-61, 2008. (Pubitemid 351694453)
10. DeBerardinis RJ, Lum JJ, Hatzivassiliou G and Thompson CB: The biology of cancer: metabolic reprogramming fuels cell growth and proliferation. Cell Metab 7: 11-20, 2008.
11. Mathupala SP, Ko YH and Pedersen PL: Hexokinase-2 bound to mitochondria: cancer's stygian link to the 'Warburg Effect' and a pivotal target for effective therapy. Semin Cancer Biol 19: 17-24, 2009.
12. Mazurek S: Pyruvate kinase type M2: a key regulator within the tumour metabolome and a tool for metabolic profiling of tumours. Ernst Schering Found Symp Proc 99-124, 2007.
13. Robey RB and Hay N: Is Akt the 'Warburg kinase'? Akt-energy metabolism interactions and oncogenesis. Semin Cancer Biol 19: 25-31, 2009.
14. Semenza GL: HIF-1 mediates the Warburg effect in clear cell renal carcinoma. J Bioenerg Biomembr 39: 231-234, 2007.
15. Gottfried E, Kunz-Schughart LA, Ebner S, Mueller-Klieser W, Hoves S, Andreesen R, Mackensen A and Kreutz M: Tumor-derived lactic acid modulates dendritic cell activation and antigen expression. Blood 107: 2013-2021, 2006. (Pubitemid 43289385)
16. Fischer K, Hoffmann P, Voelkl S, Meidenbauer N, Ammer J Edinger M, Gottfried E, Schwarz S, Rothe G, Hoves S, Renner K, Timischl B, Mackensen A, et al: Inhibitory effect of tumor cell-derived lactic acid on human T cells. Blood 109: 3812-3819, 2007 (Pubitemid 46641732)
17. Walenta S, Schroeder T and Mueller-Klieser W: Lactate in solid malignant tumors: potential basis of a metabolic classification in clinical oncology. Curr Med Chem 11: 2195-2204, 2004. (Pubitemid 38967739)
18. Walenta S and Mueller-Klieser WF: Lactate: mirror and motor of tumor malignancy. Semin Radiat Oncol 14: 267-274, 2004. (Pubitemid 38903231)
19. Warburg O: On the origin of cancer cells. Science 123: 309-314, 1956.
20. Stock C and Schwab A: Protons make tumor cells move like clockwork. Pflugers Arch 458: 981-992, 2009.
21. Kroemer G and Pouyssegur J: Tumor cell metabolism: cancer's Achilles' heel. Cancer Cell 13: 472-482, 2008. (Pubitemid 351766797)
22. Swietach P, Vaughan-Jones RD and Harris AL: Regulation of tumor pH and the role of carbonic anhydrase 9 Cancer Metastasis Rev 26: 299-310, 2007.
23. Kasid U, Pfeifer A, Weichselbaum RR, Dritschilo A and Mark GE: The raf oncogene is associated with a radiation-resistant human laryngeal cancer. Science 237: 1039-1041, 1987. (Pubitemid 17131202)
24. Mauceri HJ, Seetharam S, Salloum RM, Vokes EE and Weichselbaum RR: Treatment of head and neck and esophageal xenografts employing Alimta and concurrent ionizing radiation. Int J Oncol 19: 833-835, 2001.
25. Heo DS, Snyderman C, Gollin SM, Pan S, Walker E, Deka R, Barnes EL, Johnson JT, Herberman RB and Whiteside TL: Biology, cytogenetics, and sensitivity to immunological effector cells of new head and neck squamous cell carcinoma lines. Cancer Res 49: 5167-5175, 1989. (Pubitemid 19239363)
26. Friedl F, Kimura I, Osato T and Ito Y: Studies on a new human cell line (SiHa) derived from carcinoma of uterus. I. Its establishment and morphology. Proc Soc Exp Biol Med 135: 543-545, 1970.
27. Andreesen R, Scheibenbogen C, Brugger W, Krause S, Meerpohl HG, Leser HG, Engler H and Lohr GW: Adoptive transfer of tumor cytotoxic macrophages generated in vitro from circulating blood monocytes: a new approach to cancer immunotherapy. Cancer Res 50: 7450-7456, 1990.
28. Stevenson HC, Miller P, Akiyama Y, Favilla T, Beman JA, Herberman R, Stull H, Thurman G, Maluish A and Oldham R: A system for obtaining large numbers of cryopreserved human monocytes purified by leukapheresis and counter-current centrifugation elutriation (CCE). J Immunol Methods 62: 353-363, 1983. (Pubitemid 13003685)
29. Konur A, Kreutz M, Knuchel R, Krause SW and Andreesen R: Cytokine repertoire during maturation of monocytes to macrophages within spheroids of malignant and non-malignant urothelial cell lines. Int J Cancer 78: 648-653, 1998. (Pubitemid 28507192)
30. Silzle T, Kreutz M, Dobler MA, Brockhoff G, Knuechel R and Kunz-Schughart LA: Tumor-associated fibroblasts recruit blood monocytes into tumor tissue. Eur J Immunol 33: 1311-1320, 2003. (Pubitemid 36612030)
31. Krause SW, Kreutz M and Andreesen R: Isolation, characterization and cultivation of human monocytes and macrophages. Meth Microbiol 25: 663-684, 1998. (Pubitemid 128101951)
32. Friedl P: Prespecification and plasticity: shifting mechanisms of cell migration. Curr Opin Cell Biol 16: 14-23, 2004.
33. Juel C: Intracellular pH recovery and lactate efflux in mouse soleus muscles stimulated in vitro: the involvement of sodium/ proton exchange and a lactate carrier. Acta Physiol Scand 132: 363-371, 1988.
34. Hood JD and Cheresh DA: Role of integrins in cell invasion and migration. Nat Rev Cancer 2: 91-100, 2002. (Pubitemid 37328796)
35. Fujita S, Suzuki H, Kinoshita M and Hirohashi S: Inhibition of cell attachment, invasion and metastasis of human carcinoma cells by anti-integrin beta 1 subunit antibody. Jpn J Cancer Res 83: 1317-1326, 1992. (Pubitemid 23029840)
36. Wennerberg K, Fassler R, Warmegard B and Johansson S: Mutational analysis of the potential phosphorylation sites in the cytoplasmic domain of integrin beta1A. Requirement for threonines 788-789 in receptor activation. J Cell Sci 111: 1117-1126, 1998. (Pubitemid 28227111)
37. Baumann F, Leukel P, Doerfelt A, Beier CP, Dettmer K, Oefner PJ, Kastenberger M, Kreutz M, Nickl-Jockschat T, Bogdahn U, Bosserhoff AK and Hau P: Lactate promotes glioma migration by TGF-beta2-dependent regulation of matrix metalloproteinase-2. Neuro Oncol 11: 368-380, 2009.
38. Yang X, Wang D, Dong W, Song Z and Dou K: Suppression of Na(+)/H(+) exchanger 1 by RNA interference or amiloride inhibits human hepatoma cell line SMMC-7721 cell invasion. Med Oncol 28: 385-390, 2011.
39. Allavena P, Sica A, Solinas G, Porta C and Mantovani A: The inflammatory micro-environment in tumor progression: the role of tumor-associated macrophages. Crit Rev Oncol Hematol 66: 1-9, 2008. (Pubitemid 351324128)
40. Porta C, Subhra KB, Larghi P, Rubino L, Mancino A and Sica A: Tumor promotion by tumor-associated macrophages. Adv Exp Med Biol 604: 67-86, 2007.
41. Mantovani A, Schioppa T, Porta C, Allavena P and Sica A: Role of tumor-associated macrophages in tumor progression and invasion. Cancer Metastasis Rev 25: 315-322, 2006. (Pubitemid 44922352)
42. al-Sarireh B and Eremin O: Tumour-associated macrophages (TAMS): disordered function, immune suppression and progressive tumour growth. J R Coll Surg Edinb 45: 1-16, 2000.
43. Mantovani A, Bottazzi B, Colotta F, Sozzani S and Ruco L: The origin and function of tumor-associated macrophages. Immunol Today 13: 265-270, 1992.
44. Tsutsui S, Yasuda K, Suzuki K, Tahara K, Higashi H and Era S: Macrophage infiltration and its prognostic implications in breast cancer: the relationship with VEGF expression and microvessel density. Oncol Rep 14: 425-431, 2005.
45. Bingle L, Brown NJ and Lewis CE: The role of tumour-associated macrophages in tumour progression: implications for new anticancer therapies. J Pathol 196: 254-265, 2002. (Pubitemid 34189413)
46. Leek RD, Hunt NC, Landers RJ, Lewis CE, Royds JA and Harris AL: Macrophage infiltration is associated with VEGF and EGFR expression in breast cancer. J Pathol 190: 430-436, 2000. (Pubitemid 30163582)
47. Goede V, Brogelli L, Ziehe M and Augustin HG: Induction of inflammatory angiogenesis by monocyte chemoattractant protein-1. Int J Cancer 82: 765-770, 1999. (Pubitemid 29356979)
48. Leek RD, Lewis CE, Whitehouse R, Greenall M, Clarke J and Harris AL: Association of macrophage infiltration with angiogenesis and prognosis in invasive breast carcinoma. Cancer Res 56: 4625-4629, 1996. (Pubitemid 26338061)
49. Lin EY, Nguyen AV, Russell RG and Pollard JW: Colony-stimulating factor 1 promotes progression of mammary tumors to malignancy. J Exp Med 193: 727-740, 2001.
50. Lin EY, Li JF, Gnatovskiy L, Deng Y, Zhu L, Grzesik DA, Qian H, Xue XN and Pollard JW: Macrophages regulate the angiogenic switch in a mouse model of breast cancer. Cancer Res 66: 11238-11246, 2006. (Pubitemid 46009952)
51. Coffelt SB, Hughes R and Lewis CE: Tumor-associated macrophages: effectors of angiogenesis and tumor progression. Biochim Biophys Acta 1796: 11-18, 2009.
52. Lewis CE and Pollard JW: Distinct role of macrophages in different tumor microenvironments. Cancer Res 66: 605-612, 2006. (Pubitemid 43165918)
53. Goswami S, Sahai E, Wyckoff JB, Cammer M, Cox D, Pixley FJ, Stanley ER, Segall JE and Condeelis JS: Macrophages promote the invasion of breast carcinoma cells via a colony-stimulating factor-1/epidermal growth factor paracrine loop. Cancer Res 65: 5278-5283, 2005. (Pubitemid 40827339)
54. Lewis CE and Hughes R: Inflammation and breast cancer. Microenvironmental factors regulating macrophage function in breast tumours: hypoxia and angiopoietin-2. Breast Cancer Res 9: 209, 2007.
55. Crowther M, Brown NJ, Bishop ET and Lewis CE: Microenvironmental influence on macrophage regulation of angiogenesis in wounds and malignant tumors. J Leukoc Biol 70: 478-490, 2001. (Pubitemid 32954759)
56. Soria G and Ben-Baruch A: The inflammatory chemokines CCL2 and CCL5 in breast cancer. Cancer Lett 267: 271-285, 2008.
57. Weber C, Belge KU, von HP, Draude G, Steppich B, Mack M, Frankenberger M, Weber KS and Ziegler-Heitbrock HW: Differential chemokine receptor expression and function in human monocyte subpopulations. J Leukoc Biol 67: 699-704, 2000.
58. Dietl K, Renner K, Dettmer K, Timischl B, Eberhart K, Dorn C, Hellerbrand C, Kastenberger M, Kunz-Schughart LA, Oefner PJ, Andreesen R, Gottfried E and Kreutz MP: Lactic acid and acidification inhibit TNF secretion and glycolysis of human monocytes. J Immunol 184: 1200-1209, 2010.
59. Silzle T, Randolph GJ, Kreutz M and Kunz-Schughart LA: The fibroblast: sentinel cell and local immune modulator in tumor tissue. Int J Cancer 108: 173-180, 2004. (Pubitemid 37541767)
60. Kunz-Schughart LA and Knuechel R: Tumor-associated fibroblasts (part II): Functional impact on tumor tissue. Histol Histopathol 17: 623-637, 2002. (Pubitemid 34411215)
61. Sattler UG, Meyer SS, Quennet V, Hoerner C, Knoerzer H, Fabian C, Yaromina A, Zips D, Walenta S, Baumann M and Mueller-Klieser W: Glycolytic metabolism and tumour response to fractionated irradiation. Radiother Oncol 94: 102-109, 2010.
62. Felding-Habermann B: Integrin adhesion receptors in tumor metastasis. Clin Exp Metastasis 20: 203-213, 2003.
63. Melchiori A, Mortarini R, Carlone S, Marchisio PC, Anichini A, Noonan DM and Albini A: The alpha 3 beta 1 integrin is involved in melanoma cell migration and invasion. Exp Cell Res 219: 233-242, 1995.